Prostate Cancer
News and reporting on prostate cancer.
Roche, Stratipath Ink Deal to Distribute Breast Cancer Digital Pathology Solution
Stratipath Breast risk stratifies breast cancer by analyzing digitized histopathology slides of breast cancer tissue.
NextPoint Therapeutics Nominates Third Clinical Program Targeting HHLA2/B7-H7
The firm is hoping to advance NPX372 for treating B7-H7-expressing solid tumors and is developing an assay to identify best responders.
Researchers Aim to Confirm Benefits of Non-Hormonal Therapy for Certain Prostate Cancer Patients
Premium
Prostate cancer patients with BRCA2 and other homologous recombination repair mutations fared better on Lynparza than those without genomic alterations.
Foundation Medicine Nets FDA Approval for Tissue, Liquid NGS CDx for Lynparza Combo
The FDA approved FoundationOne CDx and FoundationOne Liquid for identifying BRCA1/2-mutated mCRPC patients eligible for Lynparza, Zytiga, and a steroid.
The firm recently started treating patients in a Phase I trial of its pol theta helicase inhibitor and filed an IND for its Werner helicase-targeted drug candidate.
Jul 18, 2024
Jun 20, 2024
Jun 3, 2024